Abstract
P2X receptors are hetero-oligomeric proteins that function as membrane ion channels and are gated by extracellular ATP. The P2X3 subunit is a constituent of the channels on a subset of sensory neurons involved in pain signaling, where ATP released by damaged and inflamed tissue can initiate action potentials. The tissue distribution of this subunit, along with experiments using antagonists, antisense oligonucleotides and gene knockouts, suggests that it may be a useful target for the development of pain therapeutics. This has been substantiated by the development by Abbott of a small molecule that selectively blocks P2X3 subunit-containing P2X receptors, and which is effective in a range of animal models of neuropathic and chronic inflammatory pain. © Current Drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 833-840 |
| Number of pages | 7 |
| Journal | Current Opinion in Investigational Drugs |
| Volume | 4 |
| Issue number | 7 |
| Publication status | Published - 1 Jul 2003 |
Keywords
- Antagonist
- ATP
- Chronic pain
- Neuropathic pain
- P2X receptors
Fingerprint
Dive into the research topics of 'The P2X3 subunit: A molecular target in pain therapeutics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver